Matthew K Fust Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Matthew K Fust.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Matthew K Fust. Matthew K Fust is a EVP and CFO in Jazz Pharmaceuticals plc ($JAZZ) and a EVP, Chief Financial Officer in Jazz Pharmaceuticals plc ($JAZZ) and a Senior Vice President & CFO in Jazz Pharmaceuticals plc ($JAZZ) and a SVP and CFO in Jazz Pharmaceuticals plc ($JAZZ) and a Director in MACROGENICS INC ($MGNX) and a in Ultragenyx Pharmaceutical Inc. ($RARE) and a Director in Ultragenyx Pharmaceutical Inc. ($RARE) and a in Dermira, Inc. ($DERM) and a Director in Dermira, Inc. ($DERM) and a Director in Atara Biotherapeutics, Inc. ($ATRA) and a Director in Crinetics Pharmaceuticals, Inc. ($CRNX).

Address: C/O JAZZ PHARMACEUTICALS, INC. 3180 PORTER DRIVE PALO ALTO 94304 CA

Companies in which Matthew K Fust is an Insider

Atara Biotherapeutics, Inc.

Trading Symbol: ATRA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Matthew K Fust: Director
Holdings: 33,854 shares
Current Value: $509,503
Latest Transaction: Jun 17 2020
$ATRA Market Capitalization: $434.34M
$ATRA Previous Close: $15.05

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Crinetics Pharmaceuticals, Inc.

Trading Symbol: CRNX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew K Fust: Director
Holdings: 16,036 shares
Latest Transaction: Jun 22 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Dermira, Inc.

Trading Symbol: DERM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew K Fust:
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 24 2020
$DERM Market Capitalization: $1.02B
$DERM Previous Close: $29.19

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Jazz Pharmaceuticals plc

Trading Symbol: JAZZ
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew K Fust: EVP, Chief Financial Officer, EVP and CFO, SVP and CFO, Senior Vice President & CFO
Holdings: 58,948 shares
Current Value: $7,371,447
Latest Transaction: Dec 01 2008
$JAZZ Market Capitalization: $7.62B
$JAZZ Previous Close: $125.05

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

MACROGENICS INC

Trading Symbol: MGNX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew K Fust: Director
Holdings: 7,424 shares
Current Value: $138,309
Latest Transaction: May 20 2019
$MGNX Market Capitalization: $637.48M
$MGNX Previous Close: $18.63

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Ultragenyx Pharmaceutical Inc.

Trading Symbol: RARE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew K Fust: Director
Holdings: 19,731 shares
Current Value: $1,438,587
Latest Transaction: Jul 08 2020
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Matthew K Fust

Sentiment: All, ATRA, CRNX, DERM, JAZZ, MGNX, RARE

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 08 2020RAREUltragenyx Pharmac ...Fust Matthew KDirectorOption ExerciseM21.006,181129,8010
Jul 08 2020RAREUltragenyx Pharmac ...Fust Matthew KDirectorSellS90.006,181556,29013,55019.7 K to 13.6 K (-31.33 %)
Jul 08 2020RAREUltragenyx Pharmac ...Fust Matthew KDirectorBuyM21.006,181129,80119,73113.6 K to 19.7 K (+45.62 %)
Jul 06 2020RAREUltragenyx Pharmac ...Fust Matthew KDirectorOption ExerciseM21.005,000105,0006,181
Jul 06 2020RAREUltragenyx Pharmac ...Fust Matthew KDirectorSellS85.005,000425,00013,55018.6 K to 13.6 K (-26.95 %)
Jul 06 2020RAREUltragenyx Pharmac ...Fust Matthew KDirectorBuyM21.005,000105,00018,55013.6 K to 18.6 K (+36.90 %)
Jun 30 2020RAREUltragenyx Pharmac ...Fust Matthew KDirectorOption ExerciseA76.584,250325,4654,250

View all Matthew K Fust insider transactions.